Cynthia Cole
The Racing Medication and Testing Consortium (RMTC) has extended for another six months its accreditation suspension of the University of Kentucky's Equine Analytical Chemistry Laboratory. The RMTC initially suspended its accreditation of the laboratory back in March, following news that the Horseracing Integrity and Welfare Unit (HIWU) had stopped sending samples to the lab due to "concerns with the performance" of the facility. Prior to that, the laboratory had been one of six drug testing facilities used under the Horseracing Integrity and Safety Act's (HISA) drug testing program. According to...
It has been two months since the Horseracing Integrity and Welfare Unit (HIWU) stopped sending samples to the University of Kentucky's Equine Analytical Chemistry Laboratory due to "concerns with the performance" of the facility. Prior to that, the laboratory had been one of six drug testing facilities used under The Horseracing Integrity and Safety Authority's (HISA) drug testing program. Since then, several key developments have unfurled amid limited public explanations. HISA and HIWU announced that they have opened an investigation into the UK Laboratory's performance, alongside the university's own investigation...
From an altitude of 10,000 feet, the Horseracing Integrity and Safety Act (HISA)'s mandated goal is a simple two-pronged affair. Uniformity in welfare and safety. Uniformity in drug testing. Over the past few months, the Horseracing Integrity and Welfare Unit (HIWU)--HISA's enforcement arm--has made several announcements that have peeled the curtain back on just how difficult the second part of that equation will be to accomplish. Internal reviews of the six HIWU-contracted laboratories uncovered different limits of detection in blood for diabetes drug Metformin and for benzoylecgonine (BZE), a metabolite...
Seth Fishman and federal prosecutors are at odds over what types of evidence and expert testimony will be admissible in court when the veterinarian who allegedly made and sold purportedly performance-enhancing drugs (PEDs) goes on trial in early 2022. In the form of dueling motions filed by each party Dec. 1 in United States District Court (Southern District of New York), the two sides sparred over whether a jury should hear a wide range of evidence that involves what the government is alleging as Fishman "specifically target[ing] clients in the...